However, recent data show that adipocytokines, especially adiponectin, exert various functions throughout the organism that are neither unambiguously protective nor solely harmful. In a study ...

Adiponectin levels were associated with increased likelihood of metabolic health improvements and lower risk for diabetes across 6 years.

The first piece of the puzzle is ready, and it concerns a hormone called adiponectin. This hormone regulates the body's ...

Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment. Set to be issued in February 2025, the patent will expire in 2042 and covers ...